Rosen Law Firm & The Wall Street Journal
6 shared events · Importance 3 · Last updated Aug 09, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Rosen Law Firm: The Rosen Law Firm is investigating potential securities claims against IP Group and is preparing a class action lawsuit on behalf of investors who suffered losses.
The Wall Street Journal: The Wall Street Journal published an article that brought to light the money laundering probe against IP Group, triggering the stock drop and subsequent legal investigations.
Jun 01, 2026 · 56 articles
Business
Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that has reminded Microsoft investors of the lead plaintiff deadline for a class action lawsuit.
The Wall Street Journal: The Wall Street Journal reported on the severe challenges and functionality issues plaguing Microsoft's Microsoft offerings, contributing to the adverse news.
Jun 14, 2026 · 303 articles
Regulatory
Rosen Law Firm: A law firm that announced a class action lawsuit against Microsoft and is encouraging investors to join before the lead plaintiff deadline.
The Wall Street Journal: The Wall Street Journal published articles revealing Copilot's problems, contributing to the stock decline and providing evidence for the lawsuit.
Jul 14, 2026 · 98 articles
Regulatory
Rosen Law Firm: Rosen Law Firm filed the first securities class action lawsuit against Wise and is actively reminding investors of the lead plaintiff deadline. The firm stands to gain from a successful recovery for investors.
The Wall Street Journal: The Wall Street Journal published the initial article on June 1, 2026, reporting that Belgium — Brussels' public prosecutor was close to summoning Wise over a money laundering probe. This article triggered the stock drop and subsequent lawsuits.
Jul 14, 2026 · 135 articles
Regulatory
Rosen Law Firm: Rosen Law Firm is actively representing investors in a class action lawsuit against Regencell Bioscience Holdings, seeking to recover damages for alleged securities fraud.
The Wall Street Journal: The Wall Street Journal is cited for reporting on Regencell Bioscience Holdings' unusual market valuation, providing context for the alleged disconnect from fundamentals.
Apr 25, 2026 · 206 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Rosen Law Firm and The Wall Street Journal interact across events, view sentiment trends, and discover connected entities.
Open Dashboard